VBI Vaccines Initiates Restructuring Proceedings Under CCAA to ...
CAMBRIDGE, Mass., July 30, 2024 -- (BUSINESS WIRE)--VBI Vaccines Inc. (Nasdaq: VBIV) (VBI), a biopharmaceutical company driven by immunology in the pursuit of powerful prevention and treatment...
VBI Vaccines Announces Completion of Sales Process to K2
6 days ago · VBI Vaccines Inc. is a biopharmaceutical company which, through its innovative approach to virus-like particles ("VLPs"), including a proprietary enveloped VLP ("eVLP") platform technology and a ...
VBI Vaccines Restructures and Acquired by K2 VBI Trust
6 days ago · VBI Vaccines Inc. is a biopharmaceutical company that develops vaccine candidates using innovative virus-like particles (VLP) technologies, including a proprietary enveloped VLP and mRNA-launched ...
VBI Vaccines Inc. (VBIVQ) Latest Stock News & Headlines - Yahoo …
Get the latest VBI Vaccines Inc. (VBIVQ) stock news and headlines to help you in your trading and investing decisions.
VBI Vaccines Provides an Update on its Restructuring Proceedings …
CAMBRIDGE, Mass., Dec. 10, 2024 /PRNewswire/ - VBI Vaccines Inc. ("VBI" or the "Company") today provided an update on the restructuring proceedings announced on July 30, 2024. Restructuring ...
VBI Vaccines Announces Completion of Sales Process to K2 - PR …
6 days ago · VBI Vaccines Inc. is a biopharmaceutical company which, through its innovative approach to virus-like particles ("VLPs"), including a proprietary enveloped VLP ("eVLP") platform technology and a ...
VBI Vaccines Provides an Update on its ... - Longview News-Journal
CAMBRIDGE, Mass., Dec. 10, 2024 /CNW/ - VBI Vaccines Inc. ("VBI" or the "Company") today provided an update on the restructuring proceedings announced on July 30, 2024.
Brii Biosciences acquires VBI Vaccines' drug assets for $18M
Jan 2, 2025 · Brii Biosciences acquires BRII-179 assets from VBI Vaccines. The $18 million deal cancels previous agreements and obligations. BRII-179 is in Phase 2 study as a hepatitis B treatment.
VBI recalls PreHevbrio and winds down operations
Nov 19, 2024 · Massachusetts, USA-based firm VBI Vaccines (Nasdaq: VBIV) has initiated a nationwide voluntary recall of PreHevbrio (hepatitis B vaccine), as it proceeds with bankruptcy and the shutdown of its operations.
VBI Vaccines provides restructuring proceedings update - MSN
VBI Vaccines (NASDAQ: VBIV) on Friday said that on August 2, 2024, the United States Bankruptcy Court for the District of Delaware granted provisional relief under Chapter 15 of the U.S....